Results 211 to 220 of about 58,549 (319)

Substitution of Val for Met at residue 239 of platelet glycoprotein Ib alpha in Japanese patients with platelet-type von Willebrand disease

, 1995
Hiroyuki Takahashi, Mitsuru Murata, Toshiaki Moriki, Hironobu Anbo, T Furukawa, Koji Nikkuni, Akira Shibata, Makoto Handa, Y Kawai, Kazuhiro Watanabe   +9 more
openalex   +1 more source

von Willebrand disease phenotype and von Willebrand factor marker genotype in Doberman Pinschers [PDF]

, 2001
Marjory B. Brooks, Hollis N. Erb, Polly Foureman, Kunal Ray   +3 more
openalex   +1 more source

Anti‐ADAMTS13 Antibodies Trajectory is Associated With ADAMTS13 Recovery in Immune‐Mediated TTP

American Journal of Hematology, Volume 100, Issue 10, Page 1736-1746, October 2025.
Anti‐ADAMTS13 IgG antibodies titer trajectory from baseline to day 7–14 post‐TPE as a reliable approach to identify iTTP patients at risk of late response to the triplet therapy regimen. ABSTRACT Current triplet regimens associating therapeutic plasma exchange (TPE), immunosuppression with corticosteroids and rituximab, and caplacizumab have ...
Marie Robert, Arthur Mageau, Ygal Benhamou, François Provôt, Jehane Fadlallah, Lionel Galicier, Elie Azoulay, Hafid Ait‐Oufella, Tomas Urbina, Pascale Poullin, Alain Wynckel, Coralie Poulain, Nihal Martis, Pierre Perez, Virginie Rieu, Yahsou Delmas, Jean‐Michel Halimi, Christelle Barbet, Amélie Seguin, Valérie Chatelet, Jean‐François Augusto, Mathieu Legendre, Olivier Moranne, Carole Philipponnet, Bérengère Cador, Raïda Bouzid, Bérangère S. Joly, Agnès Veyradier, Paul Coppo, on behalf of the French Reference Center for Thrombotic Microangiopathies, Augusto Jean‐François, Azoulay Elie, Barbay Virginie, Benhamou Ygal, Charasse Christophe, Charvet‐Rumpler Anne, Chauveau Dominique, Ribes Davis, Choukroun Gabriel, Coindre Jean‐Philippe, Coppo Paul, Delmas Yahsou, Kwon Theresa, Salanoubat Célia, Dossier Antoine, Fain Olivier, Ville Simon, Frémeaux‐Bacchi Véronique, Galicier Lionel, Grangé Steven, Guidet Bertrand, Halimi Jean‐Michel, Hamidou Mohamed, Neel Antoine, Fornecker Luc‐Matthieu, Hié Miguel, Jacobs Frédéric, Joly Bérangère, Kanouni Tarik, Kaplanski Gilles, Rieu Claire, Le Guern Véronique, Moulin Bruno, Rebibou Jean‐Michel, Ojeda Uribe Mario, Parquet Nathalie, Pène Frédéric, Perez Pierre, Poullin Pascale, Marie Manon, Presne Claire, Provôt François, Mesnard Laurent, Saheb Samir, Seguin Amélie, Servais Aude, Stépanian Alain, Veyradier Agnès, Vigneau Cécile, Wynckel Alain, Zunic Patricia   +80 more
wiley   +1 more source

Biomarkers of Endothelial Damage and Disease Severity in COVID-19 Patients. [PDF]

Curr Issues Mol Biol
Tsiatsiou P, Pilalas D, Tsaireli V, Lanta A, Meletis G, Kassomenaki A, Tza E, Tampakas L, Gkeka H, Papaioannou M, Protonotariou E, Skoura L.   +11 more
europepmc   +1 more source

Von Willebrand Disease in a Thoroughbred Mare and Foal [PDF]

, 2001
Rhonda A. Rathgeber, Marjory B. Brooks, Fairfield T. Bain, T. D. Byars   +3 more
openalex   +1 more source

Standardization of Terminology, Definitions, and Outcome Criteria for Bleeding in Hereditary Hemorrhagic Telangiectasia: International Consensus Report

American Journal of Hematology, Volume 100, Issue 10, Page 1813-1827, October 2025.
ABSTRACT Hereditary hemorrhagic telangiectasia (HHT, Osler‐Weber‐Rendu disease) is the second most common inherited bleeding disorder worldwide, affecting approximately 1 in 5000 people. Development of disease‐modifying and efficacious hemostatic agents to treat HHT has finally begun after decades without such medical therapies.
Hanny Al‐Samkari, Raj S. Kasthuri, Hans‐Jurgen Mager, Jenny Y. Zhou, Marcelo M. Serra, Bethany T. Samuelson‐Bannow, Layla N. Van Doren, Jay F. Piccirillo, Marianne S. Clancy, Keith R. McCrae, Sonia M. Thomas, Antoni Riera‐Mestre, Allyson M. Pishko, Sarah Sewaralthahab, James R. Gossage, Vivek N. Iyer, Cedric Hermans, Adrienne Hammill, Ingrid Winship, Meir Mei‐Zahav, Annette von Drygalski, Scott Olitsky, Marie E. Faughnan   +22 more
wiley   +1 more source

Incidental Finding of Combined Factor V and VIII Deficiency in the Setting of a Preoperative Evaluation: A Case Report. [PDF]

Cureus
Luzarraga JL, Purow JI, Berkman A.
europepmc   +1 more source

Phenotype changes resulting in high-affinity binding of von Willebrand factor to recombinant glycoprotein Ib-IX: analysis of the platelet-type von Willebrand disease mutations [PDF]

, 2001
A. Sasha Tait, Susan L. Cranmer, Shaun P. Jackson, Ian W. Dawes, Beng H. Chong   +4 more
openalex   +1 more source

Emerging Strategies for Platelet‐Modified Nanoparticles in Targeted Tumor Therapy

Advanced NanoBiomed Research, Volume 5, Issue 10, October 2025.
This review highlights innovative strategies using platelet‐modified nanoparticles to target tumors more precisely. By mimicking platelet functions, these biomimetic carriers improve tumor homing, enhance drug delivery, and reduce immune clearance.
Chunyu Bai, Lan Sun, Yimin Cui, Huan Meng, Jiulong Li, Qian Xiang   +5 more
wiley   +1 more source

Sodium butyrate targets VWF to inhibit cigarette smoke extract-induced endothelial cell-macrophage crosstalk in regulating inflammatory response. [PDF]

Respir Res
Ma X, Zhou J, Yang S, Zhang Y, Zhu C, Sun Y, Miao J, Mo H.   +7 more
europepmc   +1 more source